Singapore’s Communicable Diseases Agency (CDA) has received a new international responsibility after the World Health Organization (WHO) designated it as a collaborating centre for infection prevention and control on Nov. 16, 2026.
The designation gives Singapore a larger role in helping other countries strengthen healthcare safety, monitor infections acquired in medical facilities and develop better infection-control practices. It also creates an opportunity for the country to learn from international health experts and improve its own healthcare system.
The development comes as infectious diseases continue to challenge health authorities worldwide, with antimicrobial resistance, changing climate conditions, vaccine scepticism and the possibility of another pandemic emerging as major public health concerns.
For Singapore, the new WHO designation is more than international recognition. It places the country’s public health expertise within a broader regional effort to make hospitals, community healthcare facilities and long-term care institutions better prepared to prevent infections.
What Singapore’s New WHO Designation Means
The WHO collaborating centre designation places CDA in a position to contribute technical knowledge and practical experience to international infection prevention initiatives.
In his Nov. 16 address at the National Infection Prevention and Control Healthcare Conference 2026, Singapore Minister for Health Ong Ye Kung confirmed that CDA would work with WHO and its member states, particularly across the Western Pacific Region.
Its responsibilities will include contributing to infection prevention and control policies, improving infection surveillance, helping develop guidelines and strengthening healthcare capabilities.
The designation also makes CDA the first WHO collaborating centre dedicated to strengthening health systems through infection prevention and control, as confirmed in the Ministry of Health’s official conference speech. Ministry of Health
For participating countries, this creates another avenue to access technical cooperation and practical knowledge that can help strengthen their healthcare systems.
However, the designation does not automatically mean that every participating country will receive new medical equipment, additional funding or immediate improvements in hospital facilities. Its primary value lies in technical cooperation, institutional development and knowledge exchange.
Why Infection Prevention Matters Beyond Hospitals
Healthcare-associated infections are illnesses that patients acquire while receiving medical treatment or care. They can affect people in hospitals, community healthcare facilities and long-term care institutions.
Preventing these infections requires more than responding when patients become ill. Healthcare facilities need consistent procedures covering hygiene, environmental cleaning, surveillance, staff education and outbreak management.
Singapore has been developing its national infection prevention framework for more than a decade.
The Ministry of Health appointed the National Infection Prevention and Control Committee in 2014 to help consolidate national guidelines and support healthcare facilities in meeting infection-control standards.
By 2017, Singapore had introduced national infection prevention guidelines for acute healthcare facilities. These established a reference for healthcare professionals and hospital management when developing infection-control programmes.
The government subsequently expanded its guidance to other healthcare settings, including primary care, community hospitals, outpatient dialysis centres and long-term care facilities. Ministry of Health+3
This history matters because infection prevention cannot depend on a single hospital or government department. It requires coordinated practices across the healthcare system.
Four Major Threats Complicate the Fight Against Infectious Diseases
Ong identified four challenges that could make infectious disease prevention more difficult in the coming years.
1. Antimicrobial resistance
Antimicrobial resistance (AMR) happens when microorganisms develop the ability to survive medicines that previously controlled or eliminated them.
One major concern is the inappropriate use of antibiotics, particularly when they are prescribed for viral infections.
Ong highlighted the importance of responsible antibiotic use in hospitals, communities and agricultural activities.
He also cited research estimating that antimicrobial resistance directly caused 1.14 million deaths worldwide in 2021, with the annual figure projected to approach 2 million by 2050.
Singapore has already incorporated this concern into its national policies through its National Strategic Action Plan on Antimicrobial Resistance, version 2.0, published on Nov. 12, 2025.
The plan involves the Communicable Diseases Agency, National Environment Agency, National Parks Board, PUB and Singapore Food Agency, reflecting the government’s One Health approach to human, animal and environmental health. Ministry of Health+1
2. Climate change and infectious diseases
Environmental changes can influence where disease-carrying organisms survive and reproduce.
Ong discussed how rising temperatures have contributed to the expansion of mosquito habitats into locations that previously experienced less exposure to certain mosquito-borne diseases.
For tropical countries, including the Philippines, this issue is particularly relevant because dengue prevention already requires sustained coordination between health authorities and communities.
WWC ONE MEDIA previously examined the importance of monitoring mosquito-borne infections in its report on rising dengue cases and hospital preparedness in the Philippines.
Singapore’s experience with dengue control, including Project Wolbachia, is among the areas Ong identified as useful knowledge that the country can share internationally. Ministry of Health
3. Vaccine scepticism
Another concern involves declining confidence in vaccines and the spread of misinformation about immunisation.
Ong pointed to the resurgence of measles in several countries as an example of how vaccine scepticism can undermine public health protection.
He emphasised the importance of education, transparency and explaining the benefits and risks of vaccines.
The challenge is not limited to convincing people to receive vaccinations. Health authorities must also maintain public confidence through reliable information and clear communication.
4. The threat of another pandemic
The fourth challenge is preparing for another major infectious disease emergency.
The COVID-19 pandemic demonstrated how quickly an infectious disease can disrupt healthcare systems, international travel, businesses and everyday life.
Ong highlighted continuing efforts to strengthen healthcare preparedness and support the development of vaccines that could potentially be made available within 100 days of identifying a new pandemic threat.
He also discussed vaccine research targeting the Bundibugyo strain of Ebola, including a candidate being developed in Singapore through a collaboration involving Hilleman Laboratories. Ministry of Health
How Singapore Plans to Share Its Healthcare Expertise
Singapore’s international health cooperation is not starting from zero.
The country has been using the Singapore Cooperation Programme to provide technical assistance and capacity-building opportunities to developing countries.
In his conference speech, Ong said more than 3,100 government officials from other countries had benefited from Singapore’s public health courses.
He also identified the work of CDA and the National Centre for Infectious Diseases through the WHO-coordinated Global Infection Prevention and Control Network.
The new designation provides another platform for these activities.
CDA’s collaboration with WHO will focus particularly on supporting countries in the Western Pacific through technical cooperation, infection surveillance, guideline development and capability building.
This could prove valuable for healthcare systems that need assistance strengthening infection prevention procedures across different types of medical facilities.
Singapore will also benefit from exchanging knowledge with international partners, allowing its own healthcare institutions to learn from developments and practical experiences elsewhere.
Why the Development Matters to the Philippines
The Philippines is among the countries that could benefit from stronger regional cooperation on infectious disease prevention.
Hospitals and healthcare facilities must manage infection risks while dealing with a wide range of public health challenges, including dengue, influenza, tuberculosis and antimicrobial resistance.
The importance of prevention is particularly relevant when hospitals experience increased patient demand.
Singapore’s experience in developing national infection-control guidelines, surveillance systems and institutional cooperation could provide useful lessons for countries working to strengthen healthcare standards.
For example, Singapore’s recent attention to influenza surveillance and vaccination illustrates how monitoring infectious disease trends remains important even outside major pandemic emergencies.
WWC ONE MEDIA has also reported on Singapore’s influenza activity and its seasonal vaccine preparations.
The regional value of the new WHO designation will ultimately depend on how effectively countries translate shared expertise into stronger local programmes.
For the Philippines, cooperation in infection surveillance, hospital preparedness and responsible antibiotic use could complement existing public health initiatives.
The designation does not guarantee immediate changes to Philippine healthcare services, but it creates another opportunity for regional knowledge exchange.
What Happens Next
CDA will work with WHO and member states, particularly in the Western Pacific Region, on infection prevention and control initiatives.
The areas identified in the Singapore government’s announcement include policy development, infection surveillance, technical guidance and healthcare workforce capabilities.
The next important measure will be the practical implementation of these activities.
Progress will depend on how effectively technical recommendations reach hospitals, community healthcare facilities and long-term care institutions.
It will also depend on whether participating countries can adapt international guidance to their own healthcare systems, available resources and local disease risks.
For Singapore, the challenge is to turn its international recognition into practical improvements at home while contributing meaningfully to regional preparedness.
The wider objective is straightforward: prevent infections before they become larger healthcare problems.
Frequently Asked Questions
1. What is Singapore’s Communicable Diseases Agency?
The Communicable Diseases Agency is Singapore’s national agency responsible for communicable disease prevention, surveillance and response.
2. What did WHO designate Singapore’s CDA to become?
WHO designated CDA as a collaborating centre for infection prevention and control, making it the first centre dedicated to strengthening health systems through infection prevention and control.
3. What will the WHO collaborating centre do?
It will contribute to infection-control policies, surveillance, guideline development, technical cooperation and healthcare capability building, particularly in the Western Pacific Region.
4. Can the Philippines benefit from Singapore’s new designation?
Yes. The Philippines could benefit from regional knowledge exchange, technical cooperation and shared approaches to improving infection prevention and healthcare preparedness. Actual benefits will depend on future cooperation and implementation.
5. Does the designation mean Singapore can prevent another pandemic?
No. The designation strengthens international cooperation and infection prevention capabilities, but it cannot guarantee that another pandemic will not occur.
The broader goal is to improve preparedness, detect threats earlier and reduce the impact of infectious diseases through stronger healthcare systems.
Editorial note: The article is based on Singapore Ministry of Health speeches and published government infection-control guidelines. The three WWC internal links above are existing published articles, and their pages were opened successfully.
